Powder volume of linezolid
Reading File
Searching the Web
linezolid powder volume displacement value oral suspension reconstitution
Finding Sources
Reading Web Page
https://labeling.pfizer.com/ShowLabeling.aspx?id=13402
Here is the complete answer on linezolid powder volume (displacement volume):
Linezolid - Powder Volume (Displacement Volume)
ZYVOX Oral Suspension (100 mg/5 mL)
The official Pfizer prescribing information (ZYVOX for Oral Suspension) provides the following reconstitution data:
| Parameter | Value |
|---|---|
| Diluent added (distilled water) | 123 mL |
| Final constituted volume | 150 mL |
| Powder volume (displacement volume) | 150 - 123 = 27 mL |
| Concentration after constitution | 100 mg / 5 mL |
| Total drug content per bottle | 3,000 mg (3 g) |
Calculation:
Powder volume = Final volume - Volume of diluent added = 150 mL - 123 mL = 27 mL
Reconstitution Instructions
- Gently tap the bottle to loosen the powder
- Add 123 mL of distilled water in two portions
- After the first half, shake vigorously to wet all powder
- Add the second half and shake vigorously for a uniform suspension
- Do not shake before use - gently invert 3-5 times
- Store at room temperature; use within 21 days after constitution
Key Notes
- Linezolid IV (2 mg/mL bags) is a ready-to-use solution - there is no powder to reconstitute, so powder volume is not applicable for the IV formulation
- Powder volume is relevant only for the oral suspension granule formulation
- The Pfizer/ZYVOX prescribing information is the authoritative source for these values
Sytup of linezolid calculation
Finding Sources
Searching the Web
linezolid oral suspension 100mg/5ml dose calculation pediatric adults
Reading Web Page
https://www.drugs.com/dosage/linezolid.html
Here is a full breakdown of linezolid syrup (oral suspension) dose calculations:
Linezolid Oral Suspension - Dose Calculation
Available concentration: 100 mg / 5 mL (= 20 mg/mL)
Step 1 - Find the Dose (by Age Group)
| Patient Group | Dose | Frequency |
|---|---|---|
| Preterm neonate (<34 wks gestation, age <7 days) | 10 mg/kg | Every 12 hours |
| Term neonate (≥34 wks gestation, age <7 days) | 10 mg/kg | Every 8 hours |
| Infants & children (7 days - 11 years) | 10 mg/kg | Every 8 hours |
| Uncomplicated skin infection (5-11 years) | 10 mg/kg | Every 12 hours |
| Adolescents & adults (≥12 years) | 600 mg fixed | Every 12 hours |
| Uncomplicated skin infection (adults) | 400 mg fixed | Every 12 hours |
Maximum dose: 600 mg per dose (even in children)
Step 2 - Calculate the Dose in mg
Dose (mg) = Weight (kg) × 10 mg/kg
Example: Child weighing 20 kg
Dose = 20 kg × 10 mg/kg = 200 mg per dose
Step 3 - Calculate the Volume to Give
Volume (mL) = Dose required (mg) ÷ Concentration (mg/mL) Volume = Dose (mg) ÷ 20 mg/mL
Or using the labeled strength:
Volume (mL) = [Dose (mg) ÷ 100] × 5
Example: 200 mg dose
Volume = 200 ÷ 20 = 10 mL per dose
Worked Examples
| Weight | Dose (10 mg/kg) | Volume (at 100 mg/5 mL) | Frequency |
|---|---|---|---|
| 5 kg (infant) | 50 mg | 2.5 mL | q8h |
| 10 kg (toddler) | 100 mg | 5 mL | q8h |
| 15 kg | 150 mg | 7.5 mL | q8h |
| 20 kg | 200 mg | 10 mL | q8h |
| 30 kg | 300 mg | 15 mL | q8h |
| 60 kg (adult equivalent) | 600 mg (cap) | 30 mL | q12h |
Quick Formula Summary
Dose (mg) = Weight (kg) × 10
Volume (mL) = Dose (mg) ÷ 20
OR
Volume (mL) = Weight (kg) × 10 ÷ 20
= Weight (kg) ÷ 2
So for a child: Volume in mL = Half the body weight in kg (for 10 mg/kg dose at 20 mg/mL)
Duration of Treatment
| Indication | Duration |
|---|---|
| Nosocomial / community-acquired pneumonia | 10-14 days |
| Complicated skin & soft tissue infections | 14-28 days |
| VRE infections | 14-28 days |
| Uncomplicated skin infections | 10-14 days |
Source: ZYVOX Prescribing Information (Pfizer, 2024)
Vancomycin dose
Finding Sources
Searching the Web
vancomycin dosing guidelines 2024 adult pediatric AUC monitoring
Reading File
Here is a complete vancomycin dosing guide:
Vancomycin Dosing
Available Formulations
- IV: 500 mg, 1 g, 1.5 g, 2 g vials (powder for reconstitution)
- Oral capsules: 125 mg, 250 mg (for C. difficile only - NOT absorbed systemically)
- Concentration after reconstitution: typically diluted to 5 mg/mL for infusion
Adult IV Dosing
| Indication | Dose | Frequency |
|---|---|---|
| Serious infections (MRSA, endocarditis, bacteremia) | 25-30 mg/kg loading, then 15-20 mg/kg | q8-12h |
| Standard starting dose (normal renal function) | 45-60 mg/kg/day in divided doses | q8-12h |
| Traditional regimen (mild-moderate) | 1 g (~30 mg/kg/day) | q12h |
| Critically ill / loading dose | 20-25 mg/kg | Single loading dose |
| Meningitis | 30-60 mg/kg/day | 2-3 divided doses |
| Maximum single dose | 3 g | - |
Pediatric IV Dosing
| Age Group | Dose | Frequency |
|---|---|---|
| Neonates (<1 week, term) | 15 mg/kg | q12h |
| Neonates (1-4 weeks) | 10-15 mg/kg | q8h |
| Infants & children (>1 month) | 10-15 mg/kg | q6h |
| Children (serious infections) | 40-60 mg/kg/day | 3-4 divided doses |
| Max pediatric dose | 60 mg/kg/day (not to exceed adult dose) | - |
Oral Vancomycin (C. difficile ONLY)
| Indication | Dose | Frequency |
|---|---|---|
| C. difficile colitis | 125 mg | q6h x 10 days |
| Severe/recurrent CDI | 500 mg | q6h x 10 days |
Oral vancomycin is NOT absorbed - it acts locally in the gut only.
Renal Dose Adjustment (IV)
| CrCl (mL/min) | Dosing Interval |
|---|---|
| >90 | q6-8h |
| 50-90 | q12h |
| 10-50 | q24-48h |
| <10 (no dialysis) | q48-96h (monitor levels) |
| Hemodialysis | 1 g loading, then 500 mg after each session |
Therapeutic Drug Monitoring (TDM) - Current Guidelines
The ASHP/IDSA/PIDS 2020 guidelines shifted from trough-only monitoring to AUC-guided dosing:
| Parameter | Target |
|---|---|
| AUC/MIC ratio (preferred) | 400-600 mg·h/L (assuming MIC = 1 mg/L) |
| Trough (if AUC not available) | 15-20 mcg/mL (serious infections) |
| Peak | Keep <60 mcg/mL (to avoid ototoxicity) |
| Trough timing | Draw 30 min before next dose |
| Peak timing | Draw 1-2 hours after infusion ends |
Infusion Rate (Important)
- Infuse over at least 60 minutes (preferably 1-2 hours)
- For doses >1 g: infuse over 1.5-2 hours
- Rapid infusion causes Red Man Syndrome (histamine-mediated flushing, erythema of face/neck/upper torso)
- Prevented by slowing infusion or pre-treating with diphenhydramine
Quick Dose Calculation Example
Patient: 70 kg adult, normal renal function, MRSA bacteremia
Loading dose = 70 kg × 25 mg/kg = 1,750 mg (round to 1,750 mg or 2 g) Maintenance = 70 kg × 15-20 mg/kg = 1,050-1,400 mg q12h (round to 1 g - 1.5 g q12h) Total daily dose = 45-60 mg/kg/day = 3,150-4,200 mg/day ÷ by frequency
Sources: - Katzung's Basic & Clinical Pharmacology, 16th Ed., p.1257 | - Harrison's Principles of Internal Medicine, 22E | ASHP/IDSA Vancomycin Guidelines 2020
Formulations
Finding Sources
Searching the Web
vancomycin all formulations available strengths oral IV topical 2024
Reading Web Page
https://reference.medscape.com/drug/firvanq-vancocin-vancomy…
Here is a complete breakdown of all vancomycin formulations:
Vancomycin - All Formulations
1. IV Injection - Lyophilized Powder for Reconstitution (Generic)
The most commonly used form in hospitals.
| Vial Strength | Reconstitution | Resulting Concentration |
|---|---|---|
| 500 mg | Add 10 mL sterile water | 50 mg/mL |
| 1 g | Add 20 mL sterile water | 50 mg/mL |
| 1.5 g | Add 30 mL sterile water | 50 mg/mL |
| 5 g (bulk) | Add 100 mL sterile water | 50 mg/mL |
After reconstitution, further dilute in 100-250 mL of NS or D5W before infusing. Final infusion concentration: typically 5 mg/mL.
2. IV Injection - Premixed Ready-to-Use Bags (GALAXY containers)
Frozen, iso-osmotic, premixed - thaw before use. No reconstitution needed.
| Strength | Volume | Concentration | Diluent |
|---|---|---|---|
| 500 mg | 100 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 750 mg | 150 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 1 g | 200 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 1.25 g | 250 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 1.5 g | 300 mL | 5 mg/mL | D5W or 0.9% NaCl |
3. IV Injection - Ready-to-Infuse Solution (Tyzavan)
Brand-name, ready-to-infuse formulation. Same strengths as GALAXY bags. No preparation needed.
4. Oral Capsules - Vancocin (Brand) / Generic
Used ONLY for GI infections - NOT absorbed systemically.
| Strength |
|---|
| 125 mg capsules |
| 250 mg capsules |
- Indications: C. difficile-associated diarrhea, staphylococcal enterocolitis
- Store at 15-30°C
5. Powder for Oral Solution - Firvanq (Kit)
Convenient for patients who cannot swallow capsules (pediatric/elderly).
| Strength | Form |
|---|---|
| 25 mg/mL | After constitution |
| 50 mg/mL | After constitution |
- Indications: same as oral capsules (C. difficile, staphylococcal enterocolitis)
- Available for adults and pediatric patients <18 years
Summary Table
| Formulation | Brand | Route | Use |
|---|---|---|---|
| Lyophilized powder vials (500 mg, 1 g, 1.5 g, 5 g) | Generic | IV only | Systemic infections (MRSA, endocarditis, etc.) |
| Premixed frozen bags (500 mg - 1.5 g / 5 mg/mL) | Generic (GALAXY) | IV only | Systemic infections |
| Ready-to-infuse solution | Tyzavan | IV only | Systemic infections |
| Capsules (125 mg, 250 mg) | Vancocin | Oral only | C. diff, staphylococcal enterocolitis |
| Powder for oral solution (25 & 50 mg/mL) | Firvanq | Oral only | C. diff, staphylococcal enterocolitis |
Key Points
- IV vancomycin is NOT given orally - the premixed bags are strictly IV only
- Oral vancomycin is NOT absorbed - it stays in the gut and has no systemic effect
- The two routes serve completely different purposes and are NOT interchangeable
- IV infusion rate: ≤10 mg/min (or over at least 60 minutes) to prevent Red Man Syndrome
This is a shared conversation. Sign in to Orris to start your own chat.